Research & Innovation

Brain Clinical Trials

Clinical Trials

GTM-101

A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms (NCT04427384)

Physician & Study Coordinator

Physician

William Smith, MD

Study Coordinator

Amy Grossman RN
484-658-1788
Amy.Grossman@sluhn.org

Close

Synopsis

Synopsis: This study will evaluate real-world clinical outcomes and patient reported outcomes that measure the effecitveness and safety of GammaTiles™ (GT).

Close

Eligibility Criteria
  • Patients must be scheduled to undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles
  • Patients must be able to undergo pre- and post-operative imaging for disease implant assessment
  • Patients must be fluent in either English or Spanish to allow for informed consent and completion of Quality of Life tests

Close